Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Runben Biotechnology CoSHSE:603193 -1.79%72 Gross Margin % is 59.10% as of Mar. 2026, which is 9% above its 10-year median of 54.19. GuruFocus rates SHSE:603193 with a GF Score™ of 72/100 and a GF Value™ of ¥28.24 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 1,910 Consumer Packaged Goods companies, Runben Biotechnology Co ranks better than 89.63% on this metric.
SHSE:603193's Gross Margin % is ranked better than 89.63% of 1910
companies
in the Consumer Packaged Goods industry
Industry Median: 26.37
vs SHSE:603193: 58.54
Runben Biotechnology Co had a gross margin of 59.10% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Runben Biotechnology Co was 2.40% per year.
Runben Biotechnology Co (SHSE:603193) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Runben Biotechnology Co had a gross margin of 59.10% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Runben Biotechnology Co Gross Margin % Related Terms
Runben Biotechnology Co Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:603193 vs PG, CL, KVUE: Gross Margin % Comparison
For the Household & Personal Products subindustry, Runben Biotechnology Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Runben Biotechnology Co Gross Margin % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Runben Biotechnology Co's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Runben Biotechnology Co's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Runben Biotechnology Co (SHSE:603193) has a Gross Margin % of 59.10% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Runben Biotechnology Co and its competitors. This is near median its historical median of 54.19. Over the past decade, Runben Biotechnology Co's Gross Margin % has ranged from 52.53 to 58.54. According to the industry distribution chart, Runben Biotechnology Co ranks #198 out of 1910 companies in the Consumer Packaged Goods industry, placing it in the top 10.4%.
Is Runben Biotechnology Co's Gross Margin % too high?
Runben Biotechnology Co's current Gross Margin % of 59.10% is near median its 10-year median of 54.19. Over the past 10 years, this metric has ranged from a low of 52.53 to a high of 58.54. The Consumer Packaged Goods industry median Gross Margin % is 26.37. Runben Biotechnology Co's value of 59.10% is 124.1% above this industry median. Based on the distribution chart, Runben Biotechnology Co ranks #198 out of 1910 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Runben Biotechnology Co has a GF Score™ of 72/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Runben Biotechnology Co's Gross Margin % compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Runben Biotechnology Co ranks #198 out of 1910 companies for Gross Margin %. This places Runben Biotechnology Co in the top 10% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 26.37. Runben Biotechnology Co's value of 59.10% is 124.1% above this benchmark. Historically, Runben Biotechnology Co's own Gross Margin % has ranged from 52.53 to 58.54 over the past decade. While the company's 10-year median is 54.19 vs. the industry median of 26.37, Runben Biotechnology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Consumer Packaged Goods company?
The median Gross Margin % among Consumer Packaged Goods companies is 26.37, based on 1,910 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Runben Biotechnology Co's current Gross Margin % of 59.10% is 124.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Runben Biotechnology Co and its competitors. For the Consumer Packaged Goods industry, the median Gross Margin % is 26.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Runben Biotechnology Co's current Gross Margin % is 59.10%, which is near median its own 10-year median of 54.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Runben Biotechnology Co stock overvalued right now?
Based on GuruFocus' analysis, Runben Biotechnology Co (SHSE:603193) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥28.24, compared to a current price of ¥21.96 — trading 22.2% below its estimated fair value. The current Gross Margin % is 59.10%, which is near median its 10-year median of 54.19 and 124.1% above the Consumer Packaged Goods industry median of 26.37. Runben Biotechnology Co's overall GF Score™ is 72/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Runben Biotechnology Co (SHSE:603193), the current Gross Margin % is 59.10% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Runben Biotechnology Co (SHSE:603193) Overvalued in 2026?
Based on GuruFocus' analysis, Runben Biotechnology Co stock appears to be undervalued.
The current stock price of ¥21.96 is trading 22.2% below its estimated GF Value™ of ¥28.24.
GuruFocus considers Runben Biotechnology Co to be Modestly Undervalued.
Key valuation signals for SHSE:603193:
Gross Margin %: 59.10% (near median its 10-year median of 54.19)
GF Value™: ¥28.24 vs. price of ¥21.96 (22.2% below fair value)
Industry Position: 124.1% above the Consumer Packaged Goods median (#198 of 1910)
No single metric tells the full story. See the SHSE:603193 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603193 has been successfully added to your 
